Guest guest Posted January 6, 2011 Report Share Posted January 6, 2011 This multi centre, Phase IV, single-arm study will evaluate the efficacy and safety of MabThera (rituximab) in combination with fludarabine and cyclophosphamide in UNTREATED patients with B-cell chronic lymphocytic leukemia and favourable somatic status. Expected enrolment 200. Link: http://clinicaltrials.gov/ct2/show/NCT01271010 ~chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.